Royal Presence Professional Services, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 190 Spring Meadows Rd, Manchester, PA 17345 Phone: 717-978-5144 Fax: 717-384-8528 |
News Archive
Jazz Pharmaceuticals plc announced today that the first patients have been enrolled in a Phase 3 clinical development program evaluating the safety and efficacy of its investigational drug candidate, JZP-110, as a wake-promoting agent in the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy or with obstructive sleep apnea (OSA).
A researcher from the University of Houston has found that adults who take prescription opioids for severe pain are more likely to have increased anxiety, depression and substance abuse issues if they also use marijuana.
Large-scale groundwater pumping is opening doors for dangerously high levels of arsenic to enter some of Southeast Asia's aquifers, with water now seeping in through riverbeds with arsenic concentrations more than 100 times the limits of safety, according to a new study from scientists at Columbia University's Lamont-Doherty Earth Observatory, MIT, and Hanoi University of Science.
A new study has found that taking probiotics could drastically reduce the response of cancer patients to immunotherapy. Patients on a fiber-rich diet showed a five-fold increase in response.
Mirna Therapeutics, Inc., a biotechnology company pioneering microRNA replacement therapy for cancer, announced the presentation today of new preclinical data on the development of a miRNA-based therapeutic candidate for primary liver cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in San Francisco, CA.
› Verified 6 days ago